Home

Adrian Kilcoyne

CIK 1857963 · Chief Medical Officer · last filed 2024-02-21

Adrian Kilcoyne is a Chief Medical Officer who has filed 11 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for CELUW, was dated Feb 21, 2024. Across all open-market trades the lifetime net is +$31.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.1K

Companies

2

Total Filings

11

Lifetime Open-Market Net

$31.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CELUW Chief Medical Officer 1,122,238 $0.00 $2.1K $0 4 2024-02-21
HUMANIGEN, INC (HGEN) Delisted Chief Medical Officer 7,000 $0.00 $1 $31.6K 7 2022-07-29

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-02-21 CELUW Mixed −52,762 -$22.9K EDGAR
2023-07-19 CELUW Grant (A) +875,000 $0 EDGAR
2023-02-22 CELUW Grant (A) +300,000 $0 EDGAR
2022-10-04 CELUW Grant (A) — $0 EDGAR
2022-07-29 HUMANIGEN, INC (HGEN) Delisted Grant (A) — $0 EDGAR
2022-03-14 HUMANIGEN, INC (HGEN) Delisted Buy (P) +12,000 $31.6K EDGAR
2022-01-14 HUMANIGEN, INC (HGEN) Delisted Grant (A) — $0 EDGAR
2022-01-04 HUMANIGEN, INC (HGEN) Delisted Grant (A) — $0 EDGAR
2021-11-26 HUMANIGEN, INC (HGEN) Delisted Disp (D) — $0 EDGAR
2021-10-04 HUMANIGEN, INC (HGEN) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.